Tortoise Investment Management’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.1K Hold
13,752
0.01% 252
2026
Q1
$59K Hold
13,752
﹤0.01% 243
2025
Q4
$123K Hold
13,752
0.01% 233
2025
Q3
$50.9K Hold
13,752
﹤0.01% 391
2025
Q2
$26.8K Hold
13,752
﹤0.01% 464
2025
Q1
$24.2K Hold
13,752
﹤0.01% 467
2024
Q4
$36.6K Hold
13,752
﹤0.01% 474
2024
Q3
$31.5K Hold
13,752
﹤0.01% 492
2024
Q2
$40.2K Hold
13,752
﹤0.01% 422
2024
Q1
$50.1K Hold
13,752
0.01% 379
2023
Q4
$20.8K Hold
13,752
﹤0.01% 474
2023
Q3
$18.4K Hold
13,752
﹤0.01% 469
2023
Q2
$24.8K Hold
13,752
﹤0.01% 444
2023
Q1
$22.8K Hold
13,752
﹤0.01% 441
2022
Q4
$26.4K Hold
13,752
﹤0.01% 414
2022
Q3
$31K Hold
13,752
0.01% 372
2022
Q2
$45K Hold
13,752
0.01% 317
2022
Q1
$72K Buy
+13,752
New +$77.3K 0.01% 268

Other funds holding NUVB

Tortoise Investment Management's NUVB Position: Q2 2026 in Review

Tortoise Investment Management held its Nuvation Bio (NUVB) position steady in Q2 2026 at 13,752 shares worth $78.1K. The position accounts for 0.01% of the portfolio, ranked #252.

Tortoise Investment Management first reported a position in NUVB in Q1 2022 and has held it in 18 quarters since. The position peaked at $123K in Q4 2025. 156 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Tortoise Investment Management held 13,752 shares of Nuvation Bio worth $78.1K as of Q2 2026.
  • Tortoise Investment Management left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up 0.01% of Tortoise Investment Management's portfolio in Q2 2026, its #252 holding.
  • Tortoise Investment Management first reported a position in Nuvation Bio in Q1 2022 and has held it in 18 quarters since.
  • Tortoise Investment Management's Nuvation Bio position peaked at $123K in Q4 2025.
  • 156 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Tortoise Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.